These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3748325)

  • 1. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
    Skoog KM; Cain ST; Nemeroff CB
    Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ; Nemeroff CB
    Neurosci Lett; 1986 Jul; 68(2):239-44. PubMed ID: 3748452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
    Blackburn A; Dewar K; Bauco P; Rompré PP
    Brain Res; 2004 Feb; 998(2):184-93. PubMed ID: 14751589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    French ED; Vantini G
    Psychopharmacology (Berl); 1984; 82(1-2):83-8. PubMed ID: 6141586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area.
    French ED
    Neuropharmacology; 1986 Apr; 25(4):447-50. PubMed ID: 2872611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.
    Voyer D; Lévesque D; Rompré PP
    Neuropharmacology; 2017 Jan; 112(Pt A):150-163. PubMed ID: 27267684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats.
    Antoniou K; Kafetzopoulos E; Papadopoulou-Daifoti Z; Hyphantis T; Marselos M
    Neurosci Biobehav Rev; 1998; 23(2):189-96. PubMed ID: 9884112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the locomotor activating effects of D-amphetamine, cocaine, and scopolamine by potassium channel modulators.
    Rosenzweig-Lipson S; Thomas S; Barrett JE
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):853-72. PubMed ID: 9278956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of context in neurotensin-induced sensitization to the locomotor stimulant effect of amphetamine.
    Rouibi K; Rompré PP
    Peptides; 2014 Aug; 58():103-7. PubMed ID: 24969625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print.
    Sanberg PR; Henault MA; Hagenmeyer-Houser SH; Russell KH
    Behav Neurosci; 1987 Feb; 101(1):131-3. PubMed ID: 3828051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
    Rompré P; Perron S
    Neuropharmacology; 2000 Jul; 39(10):1880-92. PubMed ID: 10884569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat.
    Robledo P; Maldonado R; Koob GF
    Brain Res; 1993 Sep; 622(1-2):105-12. PubMed ID: 8242350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.